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Objective: The objective of this study is to determine the role of preoperative coagulation studies in predicting 
intraoperative blood loss, in patients undergoing elective craniotomy in our tertiary hospital setting.  
Materials and Methods: This was a Quasi-experimental study conducted at the Department of Neurosurgery, 
Aga Khan University Hospital Karachi for the duration of 6 months. A non-probability consecutive sampling 
technique was employed. All admitted neurosurgery patients for elective craniotomy were enrolled and followed 
as part of the study. Laboratory values including baseline workup e.g. Complete Blood count, PT, activated 
Partial Thromboplastin Time (aPTT), Internationalized Ratio (INR) were taken preoperatively and 
postoperatively. A predesigned questionnaire for the collection of data was used, which included demographics 
and clinical information.  Approval from the university ethical committee was obtained before starting the study. 
Data was entered and analysed into SPSS version 21. Effect modifier age, gender, co-morbids, type, and duration 
of surgery, were controlled through stratification. Post-stratification paired t-test and independent-sample t-test 
were applied using P ≤ 0.05 as significant. 
Results: In this study 57 patients who underwent elective craniotomy were included to assess the mean blood loss 
and to compare mean blood loss in patients with normal and deranged coagulation profiles. The mean age of 
patients included in the study was 39.36±13.94 years with 43 (75.4%) males and 14 (24.6%) females. The mean 
preoperative haemoglobin level amongst all patients turned out to be 14.10±3.98 gm/dl. The postoperative 
haemoglobin level showed a decrease with a mean of 12.68±31.98 gm/dl. Therefore the mean difference 
calculated between pre and post-operative haemoglobin levels turned out to be 1.42±0.99 gm/dl. 
Conclusion: It is to be concluded that significant change was found in preoperative and post-operative 
Haemoglobin levels in patients undergoing elective craniotomy. There was also a highly significant difference in 
blood loss between patients having a normal versus deranged coagulation profile. However, there is a need to 
conduct more studies using a large sample size with multiple study sites in Pakistan to validate these results. 













One of the leading intraoperative complications is 
haemorrhage, and has significant implications in the 
outcome of the patient regardless of the underlying 
disease process.1 For bleeding to stop, either the 
continuity of the vessel has to be restored or the 
coagulation cascade has to kick in and plug the defect. 
Usually, the intraoperative blood loss is secondary to 
surgical defect but an inherent defect in coagulation 
may contribute as well.2 In one study, $81,942,000 
were spent yearly on the pre-operative investigation of 
coagulation profile in neurosurgical patients. On 
average, the coagulation profile (PT/PTT) costs Rs. 
1890/-($18.62) in major cities of Pakistan. Pre-
operative blood investigations are a general 
prerequisite before any surgical procedure; including 
the coagulation parameters which intuitively does 
make sense, rather than screening only the high risk or 
at risk patients3-5, this is because even slight intra-
operative or postoperative bleed may have devastating 
effects, therefore overemphasis on pre-operative 
coagulation profile for every patient undergoing 
craniotomy leads to exploitation and at times may 
produce false-positive results.6-8  
PT and aPTT are the basic measuring tools for 
evaluating a coagulation cascade.2,11,12 Although 
derangement of these parameters does equate well 
with spontaneous intracranial bleed, their value for 
assessing the risk of post-operative haemorrhage is not 
known. Universally, neurosurgeons advise 
Prothrombin Time (PT) and activated Partial 
Thromboplastin Time (aPTT) on all patients before 
operation.8-13 The significance and cost-effectiveness of 
this practice have not been questioned as such. In 
various other fields of surgery, studies have been 
conducted to look for the importance of pre-operative 
screening of PT, aPTT, but only a few such studies are 
available for neurosurgical patients. Dutzmann et al14 
from Germany showed that this practice of pre-
operative screening with PT and aPTT in elective 
neurosurgical patients is futile. B. Schramm et al10, in a 
retrospective study over a year, showed similar 
results.  
No previous studies have specifically evaluated the 
neurosurgical population, strictly speaking about 
craniotomy patients in Pakistan. This study aims to 
determine the effectiveness of pre-operative 
coagulation studies in patients undergoing elective 
craniotomy in our tertiary setting.  
 
Materials and Methods 
 
This was a Quasi-experimental study conducted at the 
Department of Neurosurgery, Aga Khan University 
Hospital Karachi. A non-probability consecutive 
sampling technique was employed. The inclusion 
criteria comprised of patients having either gender 
with ages between 18 years to 60 years undergoing 
elective craniotomy for intracranial space-occupying 
lesions e.g. meningiomas, ependymomas, 
glioblastomas, craniopharyngiomas, etc giving an 
informed oral and written consent with a baseline 
haemoglobin level cut-off of >1 l gm/dl. The patients 
excluded from the study were those who were 
admitted in intensive care units or underwent surgery 
for trauma (emergency procedures), those having 
known bleeding tendency (e.g. known traits of 
hemophilia, thalassemia), bleeding disorders (e.g. 
Idiopathic thrombocytopenic purpura, Hemophilia, 
von Willebrand Disease) assessed via past-medical 
history, those having known drug history especially 
drugs known to cause thrombocytopenia (e.g. aspirin, 
warfarin, heparin, enoxaparin), patients with known 
co-morbids e.g. liver diseases also assessed via past-
medical history and patients with no or incomplete 
pre-operative and post-operative laboratory values or 
medical records. 
All those neurosurgery patients that were given the 
admission form for elective craniotomy were enrolled 
and followed as part of the study. Laboratory values 
including baseline workup (e.g. Complete Blood 
count) taken pre-operative and post¬operative, pre-
operative coagulation profile including activated 
Partial Thromboplastin Time (aPTT), Internationalized 
Ratio (INR) with laboratory-specific reference ranges 
were noted and recorded. A predesigned 
questionnaire for the collection of data was used, 
which included demographics and clinical 
information.  Approval from the university ethical 
committee was obtained before starting the study.  
All patients admitted to the neurosurgery service 
undergoing elective craniotomy within the study 
period fulfilling the inclusion criteria, were enrolled 
using consecutive sampling technique after written 
informed consent and followed up prospectively for 6 
months. Surgeons performing the surgery included 
greater than 5 years of neurosurgical experience. The 
pre-operative assessment for each patient was 
evaluated for haemoglobin levels (Hb) and 
coagulation workup and was recorded, post-operative 
haemoglobin levels were also observed and recorded, 
and coagulation derangements were determined. 
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Data was entered and analyzed into SPSS version 21. 
Descriptive statistics were calculated, mean and 
standard deviation were calculated for quantitative 
variables like age of the patients, duration of surgery, 
coagulation profile, blood loss (in terms of pre-
operative and post-operative haemoglobin levels and 
their difference; whereas frequency and percentage 
were calculated for categorical data i.e. gender, type of 
surgery performed and co-morbids. The mean 
difference of haemoglobin (pre-operative and post-
operative) was calculated as a marker for blood loss. 
Paired sample t-test was applied in finding the 
difference in the mean haemoglobin levels (Pre-
operative and Postoperative) and independent sample 
t-test was applied to compare the difference in Hb 
levels between the normal and deranged coagulation 
profile group. Effect modifier age, gender, co-morbids, 
type, and duration of surgery, were controlled through 
stratification. Post-stratification paired t-test and 





In this study, 57 patients who underwent elective 
craniotomy were included to assess the mean blood 
loss and to also compare mean blood loss in patients 
with normal and deranged coagulation profiles. The 
mean age of patients included in the study was 
39.36±13.94 years with 43 (75.4%) males and 14 (24.6%) 
females. The mean preoperative haemoglobin level 
amongst all patients turned out to be 14.10±3.98 
gm/dl. The postoperative haemoglobin level showed a 
decrease with a mean of 12.68±31.98 gm/dl. Therefore 
the mean difference calculated between pre and post-
operative haemoglobin levels turned out to be 
1.42±0.99 gm/dl as shown in Table 1. 
The blood loss varied amongst patients and it also 
depends on the type of surgery performed. The mean 
blood loss calculated in all patients turned out to be 
422.10±299.93 millilitres with a mean coagulation 
profile investigated pre-operatively of 26.61±16.95.  
However, the mean duration of surgery for all patients 
was about 4.03±1.81 hours. When mean blood loss was 
compared amongst patients who had normal 
coagulation profiles versus those patients who had 
deranged profiles, a significant difference was found 
with a p-value of 0.0001 as shown in Table 2. 
The co-morbid conditions with which the patients 
presented to us were also taken into account. 
Therefore out of 57 patients, the incidence of 
cardiovascular disease was found in 4 (7%) patients, 
diabetes mellitus in 11 (19.3%) patients, and 14 (24.6%) 
patients were found to be hypertensive as shown in 
Table 8. The patients who underwent craniotomy had 
different indications for it, however, the most common 
condition was intracranial tumours which were 
present in 50 (87.7%) patients followed by craniotomy 
for subdural hematoma removal and craniotomy for 
evacuation of brain abscess was the least common 
indication as shown in Figure 1. 
 
Table 1: Comparison of pre and post-operative haemoglobin level (N=57) 
Haemoglobin Level (gm/dl) Mean N SD Mean Change 95% C.I P-Value 
Preoperative Haemoglobin Levels 14.10 57 1.99 1.42 1.42-1.68 0.000 
Postoperative Haemoglobin Levels 12.68 57 1.98 
 





N Mean Blood 
Loss in ml 
SD 95% C.I P-Value 
Normal 25.20 53 345.3 71.7 -24.93-15.15 0.0001 
Deranged  45.25 4 465.7 82.4 
Table 3: Frequency of Co-morbids 
CO-MORBIDS Frequency Percent 
Cardiovascular Disease Yes 4 7.0 
No 53 93.0 
Diabetes Mellitus Yes 11 19.3 
No 46 80.7 
Hypertension Yes 14 24.6 
No 43 75.4 








Haemorrhage, whether it’s intraoperative or post-
operative is a big area of concern for surgeons as it not 
only affects the outcome of the surgery but its 
replacement i.e., the blood products are a scarce 
commodity. Therefore it is understandable why 
surgery teams all over the world try to determine the 
amount of blood loss in particular surgery and cross 
matches the donors accordingly.15,16  
It is not uncommon to find a patient with a deranged 
coagulation profile. When faced with such a patient, 
the estimate of blood loss intraoperatively and post-
operatively is very crucial to prevent complications 
and even mortalities. Many deranged coagulation 
parameters are easily detected, such as 
thrombocytopenia, prolonged global INR, diminished 
levels of coagulation inhibitors, or high levels of fibrin 
degradation products. Identification of such 
coagulation abnormalities is often required since each 
cause requires different management.  
PT, aPTT, and INR is often a basic lab test that is 
required to check a patient fit for any surgical 
intervention from a coagulation point of view. The role 
of this investigation is paramount in determining the 
risk of intraoperative bleeding however its role to 
detect the risk of post-operative bleeding is still not 
very clear. The intra-operative haemorrhage can be 
detected objectively by measuring the blood in suction 
bottles, soaked gauzes, amount of intravenous fluid 
required for replacement, and by checking 
haematocrit. Post-operative blood loss, however, will 
require some other means to detect ongoing blood loss. 
In neurosurgical patients, CT scan or MRI imaging 
modalities can offer help in detecting postoperative 
blood loss.  
By segregating the elective craniotomies into those 
with normal coagulation profiles and those with 
abnormal coagulation profiles, we checked the blood 
loss and post-operative imaging between the two 
groups. The results showed that intraoperative blood 
loss was significantly affected by the deranged 
coagulation profile, being higher in those who were 
coagulopathic. However, post-operative imaging did 
not reveal any surgical bed or intracranial hematoma 
between the two groups. 
In this study mean ± Standard deviation for the 
difference of pre-and post-operative haemoglobin 
level was 1.42±0.99 with C.I (1.15…….1.68) mg/dl, and 
p-value found to be highly significant (P=0.000). In our 
study, we also found a highly significant difference in 
blood loss between normal versus deranged 
coagulation profiles i.e. (P=0.000). During the study 
period of six months, 57 patients were enrolled with a 
mean age of 39.36±13.94 years. The duration of 
surgery was 4.03±1.81 hours. Post-operative CT scan 
was done in 20 patients and MRI was done in 37 
patients and neither imaging modality showed any 
hematoma in surgical bed or cranial cavity 
postoperatively, regardless of whether the patient had 
the normal or abnormal coagulation profile before 
surgery. 
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These findings are supported by the study conducted 
by Abbasi S, et al28, who reported the mean age of 
patients was 41 years with a standard deviation of 12.5 
and a range of 19 to 67 years. The 25th percentile was 
32 years and the 75th percentile was 51 years. The 
duration of surgery was between 2 to 6 hours with a 
mean of three hrs (SD of 1 hr).  
The strengths of our study were the use of consecutive 
sampling best suited for our study design and sample 
selection, as our inclusion and exclusion criteria were 
stringent. The use of objective definitions for predictor 
and outcome variables also minimizes the source of 
bias in our study.  
The main limitations of our study were the use of a 
weak study design analysis and strength of evidence 
of which is limited and therefore the study design does 
not require any prior sample size calculation. Also, 
limited outcomes selected in our study affect the worth 
of our study. Many variables and factors have an 
association with our predictor and outcome variables 
that could have been included in our study. The use of 
non-probability sampling also limits generalizability; 
however, we had a small number of patients and 
besides the follow-up duration is short. This study was 
hospital-based; hence the figure does not reflect the 
true frequency and severity of the disease. Moreover, 
the study was conducted in one unit in the single 




It is to be concluded that a significant decline can be 
seen in post-operative haemoglobin levels, when 
compared to the pre-operative levels, in patients 
undergoing elective craniotomy. There was also a 
highly significant difference in blood loss between 
patients with a normal versus deranged coagulation 
profile. However, there is a need to conduct more 
studies using a large sample size with multiple study 
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